📅 Get ready for #RAC25! Join us in Amsterdam on Feb 27-28 for our Regulatory Affairs Conference. In Session 5, we’ll explore key changes in the Revised Variations Regulation, their impact and upcoming amendments shaping the #EUPharma legislation. 📋 ➡️

👉 Join us at #RAC25 to explore the evolving role of new technologies in shaping the future of regulatory affairs. During session 4, let's discuss AI and Real-World Evidence (RWE) in regulatory science. See you in Amsterdam on February 27-28! 📅 ➡️

👥 Ready for #BIOEQ25? Join us in Amsterdam to explore the future of #bioequivalence. In Session 2, we’ll discuss the progress of a key guideline, regulatory views, risk assessment and the role of modelling in generic medicines development. ➡️

📌 Medicines for Europe supports Ukraine's integration into the EU pharmaceutical sector. We have outlined key actions for better alignment, improved access and stronger supply chains in a recent letter to EU and Ukrainian officials. 🔗 Read our letter:

💡 How is digitalisation reshaping regulatory affairs? Join us at #RAC25 in Amsterdam for Session 3, covering digitalisation in regulatory processes, opportunities & challenges in data-driven systems and much more! ➡️ Click here to register:

🌎 On #WorldCancerDay, we call for better cancer care and equity in Europe, with key actions such as: ➡️ Promote the use of generics & biosimilars to expand patient access ➡️ Ensure reliable supply & budget efficiency ➡️ Adapt EU frameworks for #MedsRepurposing #EUCriticalHealth

🧪Biosimilar medicines bridge access, affordability and innovation. @Julie_MarJam, our Director of Biosimilar Policy & Science, outlines key strategies needed to secure the benefits of biosimilars in a recent article for the @PharmaReview. 🔗 Read more:

📅 Get ready for #BIOEQ25! On February 26, 2025, join us in Amsterdam to explore the latest updates in #bioequivalence. Let’s learn in our first session about main challenges facing the industry, the impact of ICH M13A and future developments. ➡️Register:

📢 Yesterday, we had the pleasure of welcoming the European Commissioner for Health and Animal Welfare @OliverVarhelyi to our Executive Committee meeting. We discussed key topics of cooperation in strengthening healthcare manufacturing and patient access across Europe.🔄

📌 Today, our Vice-President Elisabeth Stampa and our member Krzysztof Kopeć joined the panel on the overreliance on imports of APIs at the @Europarl_EN. Key for the #CriticalMedicinesAct are investments in sustainable manufacturing, resilient pricing and dedicated procurement.

⏰ At #RAC25, we’ll explore the Union List of Critical Medicines and its role in ensuring supply security and prevent shortages. 📅 Join us in Amsterdam on February 27-28 for Session 2! ➡️ Register: ➡️ Programme:

📊 To ensure medicines supply security, the #CriticalMedicinesAct must address: ✅ Ambitious medicines procurement reform ✅ Smarter pricing policies balancing cost & security ✅ Legislation to support #CriticalMeds sustainability 🔄 Position paper:

📢 The #CriticalMedicinesAct must prioritise EU investment in #CriticalMeds and APIs production, supported by: ✅ A new definition of innovation for state aid & IPCEI in strategic sectors ✅ Simplified regional aid for production ✅ EU health security funding #EUCriticalHealth

💡 Join the discussion on global regulatory harmonisation for the future of #bioequivalence at #BIOEQ25. Explore key issues including model-informed approached & global development of generic medicines. See you in Amsterdam on February 26, 2025! 📅 ➡️

📌On January 29, our Vice-President Elisabeth Stampa will join the @Europarl_EN SANT Committee hearing on the overreliance on API imports. We'll discuss strengthening supply chains and reforming the off-patent market to address shortages. ➡️ More info:

📅 Ready for #RAC25? Join us on Feb 27-28 in Amsterdam for expert insights on: • EU political landscape • European Commission pharmaceuticals priorities • #EUPharma updates • EMA & HMA Strategy 2028 Don't miss out! ➡️ Click here to register:

📢 As partners of @REMEDi4ALL, we are happy to invite you to register for #iDR25, the International Drug Repurposing Conference! Get ready to explore how #MedsRepurposing is crucial for advancing effective treatment options. 🤝 Secure your spot at

📢 Join us at #BIOEQ25 in Amsterdam on February 26 to discuss the future of #bioequivalence, global generic medicine development, model-informed approaches and harmonisation with industry leaders, regulators and EU officials. ➡️ Register:

📢 Register now for #RAC25! Explore the future impact of #EUPharma legislation, digitalisation in regulatory affairs, the union list of critical medicines, and how to leverage new technologies. Amsterdam, 27-28 February 2025! 📅 ➡️ Register:

📢 We are thrilled to announce @STADA’s Head of Western Europe & Germany, Stephan Eder, as our new President. With 15+ years of experience in healthcare, Stephan prioritises value, manufacturing and sustainability at the heart of his presidency. ➡️ PR: